Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Fandrick Keith R. — IRulya Therapeutics Inc. insider · InsiderLens

/ / Fandrick Keith R.

Fandrick Keith R.

Chief Operating Officer at IRulya Therapeutics Inc. · on record since Oct 19, 2026

Insider trading activity of Fandrick Keith R.

No transactions on record for Fandrick Keith R..

Track record of Fandrick Keith R.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Fandrick Keith R.

Co-insiders of Fandrick Keith R.

Bonuccelli Catherine M.IRulya Therapeutics Inc.
Bray JuneIRulya Therapeutics Inc.
Hannah BrendanIRulya Therapeutics Inc.
Janhofer GuenterIRulya Therapeutics Inc.
Lamond DavidIRulya Therapeutics Inc.
Luca BenattiIRulya Therapeutics Inc.
McLoughlin MargaretIRulya Therapeutics Inc.
Militello JohnIRulya Therapeutics Inc.
Monohon TedIRulya Therapeutics Inc.
Patni RajivIRulya Therapeutics Inc.
PATTERSON LEONE DIRulya Therapeutics Inc.
Roberts BrigetteIRulya Therapeutics Inc.
Ryan Charles S.IRulya Therapeutics Inc.
RYAN UNA SIRulya Therapeutics Inc.
Senner Christopher J.IRulya Therapeutics Inc.
Smith Karen L.IRulya Therapeutics Inc.
Thye DirkIRulya Therapeutics Inc.
Valentine James ElwoodIRulya Therapeutics Inc.
Wise John DraytonIRulya Therapeutics Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters